Patents by Inventor Ronald KALMEIJER

Ronald KALMEIJER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION
    Publication number: 20200330499
    Abstract: Described are RNA interference (RNAi) agents for inhibiting the expression of Hepatitis B Virus (HBV) used in combination with a capsid assembly modulator (CAM) and methods of administering same. The HBV RNAi agents and CAMs are administered in ratios to effectively inhibit HBV gene expression and to treat diseases and conditions associated with HBV infection.
    Type: Application
    Filed: April 17, 2020
    Publication date: October 22, 2020
    Applicant: Janssen Pharmaceuticals, Inc.
    Inventors: Michael BIERMER, Ronald KALMEIJER, Oliver LENZ, Maria Gloria BEUMONT-MAUVIEL, Jan SNOEYS, Kenneth Alan SIMMEN
  • COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION
    Publication number: 20200332297
    Abstract: Described are RNA interference (RNAi) agents for inhibiting the expression of Hepatitis B Virus (HBV) used in combination with a capsid assembly modulator (CAM) and methods of administering same. The HBV RNAi agents and CAMs are administered in ratios to effectively inhibit HBV gene expression and to treat diseases and conditions associated with HBV infection.
    Type: Application
    Filed: April 17, 2020
    Publication date: October 22, 2020
    Applicant: Janssen Pharmaceuticals, Inc.
    Inventors: Michael BIERMER, Ronald KALMEIJER, Oliver LENZ, Maria Gloria BEUMONT-MAUVIEL, Jan SNOEYS, Kenneth Alan SIMMEN